|
| Author | Device | Year | Cases | Study | Follow up | Results |
|
|
Zucherman et al. [36] | X-Stop | 2004 | 191 | Prospective comparative | 12 months | Good outcome (implant group 59%/control 12%) |
|
|
Lee et al. [35] | X-Stop | 2004 | 10 | Prospective noncomparative | 11 months | Satisfaction 70% |
|
|
Zucherman et al. [38] | X-Stop | 2005 | 191 | Prospective comparative | 24 months | Good outcome in implant group |
|
|
Anderson et al. [69] | X-Stop | 2006 | 75 | Prospective comparative | 24 months | Good outcome (implant group 63%/control 13%) |
|
|
Kondrashov et al. [40] | X-Stop | 2006 | 18 | Prospective noncomparative | 51 months | Good outcome 78% |
|
|
Hsu et al. [39] | X-Stop | 2006 | 191 | Prospective comparative | 24 months | Better outcome in implant group |
|
|
Taylor et al. [70] | Diam | 2007 | 104 | Retrospective noncomparative | 18 months | Analgesic reduced in 63.1% |
|
|
Kim et al. [62] | Diam | 2007 | 62 | Retrospective noncomparative | 12 months | Improvement in pain scores |
|
|
Siddiqui et al. [45] | X-Stop | 2007 | 40 | Prospective noncomparative | 12 months | Reoperation 8%; satisfied 71% |
|
|
Kong et al. [61] | Coflex | 2007 | 42 | Retrospective-prospective comparative | 12 months | Clinical improvement in both groups |
|
|
Verhoof et al. [71] | X-Stop | 2008 | 12 | Retrospective noncomparative | 30 months | Reoperation 58% |
|
|
Sénégas et al. [72] | Wallis | 2009 | 107 | Retrospective noncomparative | 13 years | Good outcome 80%; reoperation 20% |
|
|
Kuchta et al. [73] | X-Stop | 2009 | 175 | Prospective noncomparative | 24 months | VAS and ODI decreased 39% and 20.3% |
|
|
Sobottke et al. [31] | X-Stop | 2009 | 129 | Retrospective noncomparative | 10 months | Good symptom control |
|
|
Barbagallo et al. [74] | X-Stop | 2009 | 69 | Retrospective noncomparative | 23 months | Reoperation of 7 cases |
|
|
Richter et al. [75] | Coflex | 2010 | 60 | Prospective comparative | 12 months | No differences |
|
|
Galarza et al. [30] | Aperius | 2010 | 40 | Prospective noncomparative | 12 months | Satisfaction 90% |
|
|
van Meirhaeghe et al. [76] | Aperius | 2013 | 156 | Prospective noncomparative | 12 months | High clinical improvement in 58%;
reoperation 9% |
|
|
Surace et al. [77] | Aperius | 2013 | 37 | Retrospective noncomparative | 18 months | VAS and ODI decreased 5% and 26%;
reoperation 5.6% |
|
